Scripps College

Scripps Research is a premier non-profit biomedical research organization that bridges the gap between basic science and clinical application. Through its drug discovery division, Calibr, the institute maintains a robust internal pipeline of first-in-class therapies across oncology, immunology, and regenerative medicine. The organization is distinguished by its high-impact academic output and its success in translating laboratory discoveries into FDA-approved medicines, such as Vyndaqel and Surfaxin. With a focus on innovative modalities like switchable CAR-T cells and molecular glues, Scripps Research remains a central hub for biotech innovation and industry partnerships. Headquartered in La Jolla, California, it operates as one of the world's largest independent, non-profit biomedical research facilities.